The effectiveness of behavioral activator group therapy on resiliency and metacognitive beliefs of opioid addicts

Document Type : Research Paper

Authors

1 Department of Psychology, Boroujerd Branch, Islamic Azad University, Boroujerd, Iran.

2 Department of Psychology, Allameh Tabatabai University, Tehran, Iran.

Abstract

Abstract
Introduction: A review of research shows that opioid addicts have problems with resiliency and metacognitive beliefs. The aim of this study was to determine the effectiveness of behavioral activator group therapy on resiliency and metacognitive beliefs of opioid addicts.
Method: The research method was quasi-experimental pre-test-post-test with a control group. From the community of people addicted to opiates at Alborz Clinic in Tehran, 25 samples were selected by available methods and randomly divided into two groups. Initially, for both groups, Connor and Davidson (2003) and Wells et al (2004) metacognitive beliefs pretest were performed on both groups, and then the behavioral activator group therapy was performed in 8 sessions on the experimental group. Two post-test groups were taken. Multivariate analysis of covariance (MANCOVA) was used to analyze the data.
Results: The results of data analysis showed that behavioral activator group therapy increases resiliency and decreases metacognitive beliefs of uncontrollable control, positive beliefs about cognition, low cognitive confidence, need to control thoughts and cognition of drug addicts. Opium in the experimental group was compared with the control group (p≤ 0.001).
Conclusion: In order to improve the resiliency and metacognitive beliefs of opioid addicts, it is recommended to use behavioral activating group therapy.

Keywords


1. Ballester J, Valentine G, Sofuoglu M. Pharmacological treatments for methamphetamine addiction: current status and
future directions. Expert review of clinical pharmacology. 2017 Mar 4;10(3):305-14.
2. Miller WR, Moyers TB. The forest and the trees: relational and specific factors in addiction treatment. Addiction. 2015
Mar;110(3):401-13.
3. Arslan N, Kiper A. Self-Disclosure and Internet Addiction. Malaysian Online Journal of Educational Technology.
2018;6(1):56-63.
4. Frost MC, Lampert H, Tsui JI, Iles-Shih MD, Williams EC. The impact of methamphetamine/amphetamine use on receipt
and outcomes of medications for opioid use disorder: a systematic review. Addiction Science & Clinical Practice. 2021
Dec;16(1):1-25.
5. Tsui JI, Mayfield J, Speaker EC, Yakup S, Ries R, Funai H, Leroux BG, Merrill JO. Association between
methamphetamine use and retention among patients with opioid use disorders treated with buprenorphine. Journal of
Substance Abuse Treatment. 2020 Feb 1;109:80-5.
6. Wang Z, Li WX, Zhi-Min L. Similarity and difference in drug addiction process between heroin-and methamphetaminedependent users. Substance Use & Misuse. 2017 Mar 21;52(4):459-67.
7. Saeeidi M. Comparison of emotional malaise and resiliency of addicts with normal people. Master Thesis in Counseling.
Islamic Azad University of Ahvaz. 2013.
8. Minaei M. The effectiveness of stress management on the level of resiliency and self-efficacy of divorced women in
Shousha. Master Thesis. Khuzestan university of science and research. 2014.
9. Truxillo DM, Bauer TN, Erdogan B. Psychology and work: Perspectives on industrial and organizational psychology.
Routledge; 2015 Dec 22.
10. Pournamdarian S, Birshak B, Asgharnezhad F. Explaining the contribution of metacognitive beliefs in predicting the
symptoms of depression, anxiety and stress in nurses, Journal of Knowledge and Research in Applied Psychology, 2013;
13 (3): 94-87.
11. Dasht Bozorgi Z. Effectiveness of Behavioral Activation Therapy in Opiate-Dependent Patients' Action Resilience and
Metacognitive Beliefs. Scientific Quarterly Research on Addiction. 2018 Dec 10;12(47):287-302.
12. Zamanzadeh M. Comparison of the relationship between spiritual intelligence and metacognitive beliefs with
psychological well-being of Ahvaz nurses. Master Thesis. Khuzestan University of Research Sciences. 2014.
13. Scragg P. Metacognitive therapy developed by adrian wells. Trauma clinic LTD & university collage. London. 2010.
14. Normann N, Morina N. The efficacy of metacognitive therapy: a systematic review and meta-analysis. Frontiers in
psychology. 2018 Nov 14;9:2211.
15. Wells A. Advances in metacognitive therapy. International Journal of Cognitive Therapy. 2013 Jun;6(2):186-201.
16. Solomonov N, Bress JN, Sirey JA, Gunning FM, Flückiger C, Raue PJ, Areán PA, Alexopoulos GS. Engagement in
socially and interpersonally rewarding activities as a predictor of outcome in “Engage” behavioral activation therapy for
late-life depression. The American Journal of Geriatric Psychiatry. 2019 Jun 1;27(6):571-8.
17. Bot M, Brouwer IA, Roca M, Kohls E, Penninx BW, Watkins E, Van Grootheest G, Cabout M, Hegerl U, Gili M, Owens
M. Effect of multinutrient supplementation and food-related behavioral activation therapy on prevention of major depressive disorder among overweight or obese adults with subsyndromal depressive symptoms: the MooDFOOD
randomized clinical trial. Jama. 2019 Mar 5;321(9):858-68.
18. Kanter JW, Manos RC, Bowe WM, Baruch DE, Busch AM, Rusch LC. What is behavioral activation?: A review of the
empirical literature. Clinical psychology review. 2010 Aug 1;30(6):608-20.
19. Anderson LHThe effect of behavioral activation group therapy on the resilience, quality of life and perceived stress in
abusing in drug abuser patient. American journal of Orthodontics Orthodontics. 2014; 131(5):571-572.
20. Miles H, Andr J S. The effect of behavioral activation group therapy on the meta cognitions of abusing in drug abuser.
Journal of Clinical Psychology and Psychotherapy, 2015; 22: 80-93.
21. Loxton NJ, Dawe S. Alcohol abuse and dysfunctional eating in adolescent girls: The influence of individual differences in
sensitivity to reward and punishment. International Journal of Eating Disorders. 2001 May;29(4):455-62.
22. Whiteside SP, Inglis AL, Dyson L, Roper A, Harbottle A, Ryder J, Cowell PE, Varley RA. Error reduction therapy in
reducing struggle and grope behaviours in apraxia of speech. Neuropsychological Rehabilitation. 2012 Apr 1;22(2):267-94.
23. Phillips KA, Epstein DH, Preston KL. Psychostimulant addiction treatment. Neuropharmacology. 2014 Dec 1;87:150-60.
24. Connor KM, Davidson JR. Development of a new resilience scale: The Connor‐ Davidson resilience scale (CD‐ RISC).
Depression and anxiety. 2003 Sep;18(2):76-82.
25. Mohammadi M., Jazayeri A, Rafiei, A.H, Jokar B, & Poorshahbaz A. Investigation of family and individual variables in
individuals at risk of drug abuse. Rehabilitation Journal. 2005; 6(1): 31-36.
26. Moradi N, Ahmadi A, Naserian M, Rezaeimanesh F. The effect of group behavioral activation on the degree of resilience
and psychological toughness of drug addicts. Journal of Psychology of the Day. 2014; 8 (21): 12-18.
27. Ebrahimi A, Zanjani S, Bakhtiari R. The effectiveness of group behavioral activation therapy on irrational beliefs and
anxiety in drug addicts. Journal of Isfahan Medical School, 2012; 29: 167: 46-31.
28. Rasel H. The effect behavioral activation group therapy on the meta cognitive beliefs of abusing in drug abuser. journal of
Applied Psychology, volume 86, issue, 2013; 3: 401-409.